Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.

ABSTRACT:

SUBMITTER: Modjarrad K 

PROVIDER: S-EPMC7185789 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature